2m 2m 2m 2m 2m 2m 2m
Guided Therapeut (GTHP)
OTC
$0.17+$0.02 (+13.33%)
Price as of Oct 22, 2026- $16.4MMarket Cap
- -26.09%1-Year Change
- Medical DevicesIndustry
Guided Therapeut (GTHP)
$0.17+$0.02 (+13.33%)
GTHP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.17 | ||
Change | +$0.02 (+13.33%) | ||
Open | $0.15 | ||
High | $0.17 | ||
Low | $0.15 | ||
Previous Close | $0.15 | ||
Volume | 22,278 | ||
30-Day Average Volume | 82,943 | ||
1-Week Change | -10.53% | ||
1-Month Change | -22.89% | ||
1-Year Change | -26.09% | ||
3-Year Change | 5.18% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 96.5M | ||
Total Assets | $1.2M | ||
Market Cap | $16.4M | ||
Enterprise Value | $16.7M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$605,000.00 | ||
Free Cash Flow | -$319,000.00 | ||
EBIT | -$469,000.00 | ||
EBITDA | -$467,000.00 | ||
Net Working Capital | -$5.6M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -36 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -3 | ||
P/E | -17 | ||
PEG | N/A | ||
Price/Free Cash Flow | -51 | ||
Price/Operating Cash Flow | -51 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 800 | ||
Last Split Date | 03/29/2019 | ||
Earnings & Revenue